Harmony™ TPV Innovation Video - (04:47)
Learn how the Harmony™ Transcatheter Pulmonary Valve System was designed specifically for the native Right Ventricular Outflow Tract (RVOT) and the various anatomies.
More information (see more) Less information (see less)
SUNDAY, MAY 16, 2021
3:45-4:15 p.m. EST
Virtual innovation Stage session
Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric Congenital Heart Disease Patients
Learn more about Harmony™ Transcatheter Pulmonary Valve (TPV) from Medtronic: the first minimally invasive alternative for patients with severe pulmonary regurgitation who have a native or surgically-repaired right ventricular outflow tract (RVOT) and are clinically indicated for surgical pulmonary valve replacement. Harmony TPV allows a broader range of congenital heart disease patients access to transcatheter technology, thus fulfilling a significant unmet clinical need. This novel therapy recently received FDA approval and is now available for use in the United States.
Presenter: Doff B. McElhinney, M.D., Lucile Packard Children's Hospital at Stanford